Match tier Listed
Presence Formerly Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-08

Lindsey Barrett

Role not yet determined Is this you? Add your title

Formerly Arkansas Affiliated with UAMS through 2022.

7 h-index 9 pubs 143 cited

  • Humans
  • Herpesvirus 8, Human
  • Sarcoma, Kaposi
  • Virus Activation
  • Lung Neoplasms
  • Small Cell Lung Carcinoma
  • Mouth
  • HIV Infections
  • Porphyromonas gingivalis
  • Coinfection
  • Diffuse Intrinsic Pontine Glioma
  • Antineoplastic Agents, Phytogenic
  • Biological Products
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor

Biography and Research Information

OverviewAI-generated summary

Lindsey Barrett's research focuses on the pathogenesis of oncogenic viruses, particularly Kaposi's sarcoma-associated herpesvirus (KSHV). Her work investigates how KSHV interacts with host cells and other microbes, including SARS-CoV-2 and *Porphyromonas gingivalis*. Barrett has studied the role of KSHV in conditions such as Kaposi's sarcoma and lung cancer, exploring viral activation mechanisms and potential therapeutic targets. Her recent publications include studies on the lytic reactivation of KSHV induced by SARS-CoV-2 proteins and anti-COVID-19 drugs, as well as the coinfection of KSHV with *P. gingivalis* in HIV-positive individuals. Barrett has also explored novel therapeutic compounds for diffuse intrinsic pontine glioma and small-cell lung cancer. Her scholarship metrics include an h-index of 7 and 143 total citations across 9 publications. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Lu Dai and Steven R. Post.

Metrics

  • h-index: 7
  • Publications: 9
  • Citations: 143

Selected Publications

  • Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target (2022)
    Journal of Cellular and Molecular Medicine 16 citations DOI OpenAlex
  • Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus (2021)
    Cancer Research DOI OpenAlex
  • SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus (2021)
    Communications Biology 45 citations DOI OpenAlex
  • Kaposi's sarcoma‐associated herpesvirus and extracellular vesicles (2021)
    Journal of Medical Virology 18 citations DOI OpenAlex
  • Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis (2020)
    Frontiers in Cellular and Infection Microbiology 12 citations DOI OpenAlex
  • SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus (2020)
    bioRxiv (Cold Spring Harbor Laboratory) 14 citations DOI OpenAlex
  • Porphyromonas gingivalis coinfects with KSHV in oral cavities of HIV+ patients and induces viral lytic reactivation (2020)
    Journal of Medical Virology 13 citations DOI OpenAlex
  • Identification of new therapeutic targets and natural compounds against diffuse intrinsic pontine glioma (DIPG) (2020)
    Bioorganic Chemistry 30 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

12 Collaborators 7 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics